Tarsus Pharmaceuticals, Inc. (TARS)

Sector:
HEALTH CARE
Industry:
BIOTECHNOLOGY & LIFE SCIENCES
SIC:
BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
CEO:
Bobak Azamian
Employees:
50
15440 LAGUNA CANYON ROAD, IRVINE, CA 92618
(949) 409-9820

Tarsus Pharmaceuticals, Inc. focuses on the development and commercialization of novel therapeutic candidates for ophthalmic conditions. Its lead product candidate is TP-03, a novel therapeutic that is in Phase III for the treatment of blepharitis caused by the infestation of Demodex mites, as well as to treat meibomian gland disease. The company is also developing TP-04 for the. treatment of rosacea; and TP-05 for Lyme prophylaxis and community malaria reduction.

Data derived from most recent annual or quarterly report
Market Cap 317.932 Million Shares Outstanding26.672 Million Avg 30-day Volume 73.595 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-0.84
Price to Revenue8.1096 Debt to Equity0.0 EBITDA-13.496 Million
Price to Book Value2.7737 Operating Margin-21.318 Enterprise Value290.652 Million
Current Ratio15.33 EPS Growth0.845 Quick Ratio14.977
1 Yr BETA 0.8433 52-week High/Low 19.66 / 10.8 Profit Margin-24.2464
Operating Cash Flow Growth117.7311 Altman Z-Score23.5893 Free Cash Flow to Firm -5.594 Million
Earnings Report2023-05-10
View SEC Filings from TARS instead.

View recent insider trading info

Tarsus Pharmaceuticals, Inc. YCharts
Yahoo! Finance finviz
SEC Web Site SEC DEF 14A Filings

Funds Holding TARS (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
Click for Additional Filters
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding TARS

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Financial Reporting

Ownership

  • 4: filed on 2023-03-23 by GREENSTEIN LEONARD M.
  • 4: filed on 2023-03-23 by TREVEJO JOSE M.
  • 4: filed on 2023-03-23 by NEERVANNAN SESHADRI
  • 4: filed on 2023-03-23 by WAHL BRYAN
  • 4: filed on 2023-03-23 by AZAMIAN BOBAK R.
  • 4: filed on 2023-03-23 by WHITFIELD DIANNE C.
  • 4: filed on 2023-03-23 by MOTTIWALA AZIZ
  • 4: filed on 2023-03-21 by WHITFIELD DIANNE C.
  • 4: filed on 2023-03-21 by WAHL BRYAN
  • 4: filed on 2023-03-21 by NEERVANNAN SESHADRI

    • Events (8k)

  • 8-K: filed on 2023-03-13:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-01-05:
    Item 1.01: Entry into a Material Definitive Agreement
  • 8-K: filed on 2022-12-07:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
  • 8-K: filed on 2022-11-09:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-10-12:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-08-11:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-06-22:
    Item 5.07: Submission of Matters to a Vote of Security Holders
  • 8-K: filed on 2022-05-10:
    Item 2.02: Results of Operations and Financial Condition
  • 8-K: filed on 2022-05-04:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-05-03:
    Item 8.01: Other Events

    • Proposed Sales (Form 144)

  • 144: filed on 2023-03-16:
  • 144: filed on 2023-03-16:
  • 144: filed on 2023-03-16:
  • 144: filed on 2023-03-16:
  • 144: filed on 2023-03-16:
  • 144: filed on 2023-03-16:
  • 144: filed on 2023-03-16:
  • 144: filed on 2023-03-16:

    • Proxy

    Prospectus

    All

    Open Market Buys/Sells Last 60 Days

    Open Market Buys (P)

    none

    Open Market Sells (S)

    59 Thousand total shares from 52 transactions

    Exercise Derivative Conversion (M)

    45.1 Thousand total shares from 8 transactions

    Current/Former Insiders

    Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

    GREENSTEIN LEONARD M. CHIEF FINANCIAL OFFICER

    • Officer
    		 31,785 2023-03-21 11

    TREVEJO JOSE M. CHIEF MEDICAL OFFICER

    • Officer
    		 6,107 2023-03-21 4

    MOTTIWALA AZIZ CHIEF COMMERCIAL OFFICER

    • Officer
    		 52,829 2023-03-21 6

    NEERVANNAN SESHADRI CHIEF OPERATING OFFICER

    • Officer
    		 54,696 2023-03-21 4

    AZAMIAN BOBAK R. PRESIDENT/CEO AND BOARD CHAIR

    • Officer
    • Director
    		 1,099,176 2023-03-21 22

    WHITFIELD DIANNE C. CHIEF HUMAN RESOURCES OFFICER

    • Officer
    		 11,219 2023-03-21 6

    WAHL BRYAN GENERAL COUNSEL

    • Officer
    		 16,402 2023-03-21 6

    HOLDBROOK MARK J. V.P., CLINICAL AFFAIRS

    • Officer
    		 3,191 2023-03-17 2

    LINK WILLIAM J PHD

    • Director
    		 418,881 2023-03-15 4

    YARNO WENDY L

    • Director
    		 5,000 2022-12-02 2

    MORRISON SCOTT W

    • Director
    		 0 2022-10-06 2

    LIN ELIZABETH YEU

    • Director
    		 18,400 2022-09-14 2

    CRANE ROSEMARY A

    • Director
    		 9,000 2022-06-16 1

    CHAUDHURI BHASKAR

    • Director
    		 9,000 2022-06-16 1

    ACKERMANN MICHAEL

    • Director
    		 19,000 2022-06-16 3

    GOLDBERG ANDREW D.

    • Director
    		 9,000 2022-06-16 1

    VIVO CAPITAL IX, LLC

    VIVO CAPITAL FUND IX, L.P.

    • 10% Owner
    		 2,469,001 2022-05-05 2

    TESTER JASON E.

    • Director
    • 10% Owner
    		 20,000 2021-06-15 0

    RTW INVESTMENTS, LP

    WONG RODERICK

    • 10% Owner
    		 No longer subject to file 2021-05-07 0

    FRAZIER LIFE SCIENCES IX, L.P.

    FHMLS IX, L.P.

    FHMLS IX, L.L.C.

    TOPPER JAMES N

    HERON PATRICK J

    • 10% Owner
    		 No longer subject to file 2020-10-20 0

    HOROWITZ LIMITED PARTNERSHIP VIII

    • 10% Owner
    		 No longer subject to file 2020-10-20 0

    Insider Transactions Last 60 Days

    Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
    Disposed    		 Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

    GREENSTEIN LEONARD M. - Officer CHIEF FINANCIAL OFFICER

    		2023-03-23 20:04:57 -0400 2023-03-23 S 346 $12.15 d 31,785 direct

    MOTTIWALA AZIZ - Officer CHIEF COMMERCIAL OFFICER

    		2023-03-23 19:46:10 -0400 2023-03-23 S 372 $12.15 d 52,829 direct

    AZAMIAN BOBAK R. - Director - Officer PRESIDENT/CEO AND BOARD CHAIR

    		2023-03-23 19:50:48 -0400 2023-03-23 S 737 $12.15 d 8,597 direct

    WHITFIELD DIANNE C. - Officer CHIEF HUMAN RESOURCES OFFICER

    		2023-03-23 19:48:38 -0400 2023-03-23 S 345 $12.15 d 11,219 direct

    WAHL BRYAN - Officer GENERAL COUNSEL

    		2023-03-23 19:52:43 -0400 2023-03-23 S 371 $12.15 d 16,402 direct

    NEERVANNAN SESHADRI - Officer CHIEF OPERATING OFFICER

    		2023-03-23 19:56:35 -0400 2023-03-23 S 390 $12.15 d 54,696 direct

    TREVEJO JOSE M. - Officer CHIEF MEDICAL OFFICER

    		2023-03-23 20:02:56 -0400 2023-03-23 S 465 $12.15 d 6,107 direct

    NEERVANNAN SESHADRI - Officer CHIEF OPERATING OFFICER

    		2023-03-23 19:56:35 -0400 2023-03-22 S 379 $12.64 d 55,086 direct

    TREVEJO JOSE M. - Officer CHIEF MEDICAL OFFICER

    		2023-03-23 20:02:56 -0400 2023-03-22 S 529 $12.64 d 6,572 direct

    WAHL BRYAN - Officer GENERAL COUNSEL

    		2023-03-23 19:52:43 -0400 2023-03-22 S 357 $12.64 d 16,773 direct

    MOTTIWALA AZIZ - Officer CHIEF COMMERCIAL OFFICER

    		2023-03-23 19:46:10 -0400 2023-03-22 S 357 $12.64 d 53,201 direct

    WHITFIELD DIANNE C. - Officer CHIEF HUMAN RESOURCES OFFICER

    		2023-03-23 19:48:38 -0400 2023-03-22 S 333 $12.64 d 11,564 direct

    AZAMIAN BOBAK R. - Director - Officer PRESIDENT/CEO AND BOARD CHAIR

    		2023-03-23 19:50:48 -0400 2023-03-22 S 709 $12.64 d 9,334 direct

    GREENSTEIN LEONARD M. - Officer CHIEF FINANCIAL OFFICER

    		2023-03-23 20:04:57 -0400 2023-03-22 S 332 $12.64 d 32,131 direct

    TREVEJO JOSE M. - Officer CHIEF MEDICAL OFFICER

    		2023-03-23 20:02:56 -0400 2023-03-21 S 519 $12.89 d 7,101 direct

    MOTTIWALA AZIZ - Officer CHIEF COMMERCIAL OFFICER

    		2023-03-23 19:46:10 -0400 2023-03-21 S 349 $12.89 d 53,558 direct

    AZAMIAN BOBAK R. - Director - Officer PRESIDENT/CEO AND BOARD CHAIR

    		2023-03-23 19:50:48 -0400 2023-03-21 S 679 $12.89 d 10,043 direct

    WHITFIELD DIANNE C. - Officer CHIEF HUMAN RESOURCES OFFICER

    		2023-03-23 19:48:38 -0400 2023-03-21 S 326 $12.89 d 11,897 direct

    GREENSTEIN LEONARD M. - Officer CHIEF FINANCIAL OFFICER

    		2023-03-23 20:04:57 -0400 2023-03-21 S 326 $12.89 d 32,463 direct

    WAHL BRYAN - Officer GENERAL COUNSEL

    		2023-03-23 19:52:43 -0400 2023-03-21 S 350 $12.89 d 17,130 direct

    NEERVANNAN SESHADRI - Officer CHIEF OPERATING OFFICER

    		2023-03-23 19:56:35 -0400 2023-03-21 S 372 $12.89 d 55,465 direct

    AZAMIAN BOBAK R. - Director - Officer PRESIDENT/CEO AND BOARD CHAIR

    		2023-03-21 19:01:10 -0400 2023-03-20 S 741 $12.61 d 10,722 direct 0.8306 0.8306 2 0.0 1

    WHITFIELD DIANNE C. - Officer CHIEF HUMAN RESOURCES OFFICER

    		2023-03-21 19:17:06 -0400 2023-03-20 S 333 $12.61 d 12,223 direct 0.8306 0.8306 2 0.0 1

    GREENSTEIN LEONARD M. - Officer CHIEF FINANCIAL OFFICER

    		2023-03-21 19:03:55 -0400 2023-03-20 S 333 $12.61 d 32,789 direct 0.8306 0.8306 2 0.0 1

    HOLDBROOK MARK J. - Officer V.P., CLINICAL AFFAIRS

    		2023-03-21 19:06:38 -0400 2023-03-20 S 198 $12.61 d 3,191 direct 0.8306 0.8306 2 0.0 1

    MOTTIWALA AZIZ - Officer CHIEF COMMERCIAL OFFICER

    		2023-03-21 19:08:45 -0400 2023-03-20 S 358 $12.61 d 53,907 direct 0.8306 0.8306 2 0.0 1

    TREVEJO JOSE M. - Officer CHIEF MEDICAL OFFICER

    		2023-03-21 19:10:51 -0400 2023-03-20 S 530 $12.61 d 7,620 direct 0.8306 0.8306 2 0.0 1

    NEERVANNAN SESHADRI - Officer CHIEF OPERATING OFFICER

    		2023-03-21 19:12:51 -0400 2023-03-20 S 380 $12.61 d 55,837 direct 0.8306 0.8306 2 0.0 1

    WAHL BRYAN - Officer GENERAL COUNSEL

    		2023-03-21 19:14:59 -0400 2023-03-20 S 357 $12.61 d 17,480 direct 0.8306 0.8306 2 0.0 1

    NEERVANNAN SESHADRI - Officer CHIEF OPERATING OFFICER

    		2023-03-21 19:12:51 -0400 2023-03-17 S 360 $13.28 d 56,217 direct 0.8306 0.8306 2 0.0 1

    TREVEJO JOSE M. - Officer CHIEF MEDICAL OFFICER

    		2023-03-21 19:10:51 -0400 2023-03-17 S 504 $13.28 d 8,150 direct 0.8306 0.8306 2 0.0 1

    WAHL BRYAN - Officer GENERAL COUNSEL

    		2023-03-21 19:14:59 -0400 2023-03-17 S 339 $13.28 d 17,837 direct 0.8306 0.8306 2 0.0 1

    MOTTIWALA AZIZ - Officer CHIEF COMMERCIAL OFFICER

    		2023-03-21 19:08:45 -0400 2023-03-17 S 339 $13.28 d 54,265 direct 0.8306 0.8306 2 0.0 1

    HOLDBROOK MARK J. - Officer V.P., CLINICAL AFFAIRS

    		2023-03-21 19:06:38 -0400 2023-03-17 S 188 $13.28 d 3,389 direct 0.8306 0.8306 2 0.0 1

    WHITFIELD DIANNE C. - Officer CHIEF HUMAN RESOURCES OFFICER

    		2023-03-21 19:17:06 -0400 2023-03-17 S 316 $13.28 d 12,556 direct 0.8306 0.8306 2 0.0 1

    GREENSTEIN LEONARD M. - Officer CHIEF FINANCIAL OFFICER

    		2023-03-21 19:03:55 -0400 2023-03-17 S 316 $13.28 d 33,122 direct 0.8306 0.8306 2 0.0 1

    AZAMIAN BOBAK R. - Director - Officer PRESIDENT/CEO AND BOARD CHAIR

    		2023-03-21 19:01:10 -0400 2023-03-17 S 795 $13.28 d 11,463 direct 0.8306 0.8306 2 0.0 1

    HOLDBROOK MARK J. - Officer V.P., CLINICAL AFFAIRS

    		2023-03-17 18:22:23 -0400 2023-03-16 S 187 $13.43 d 3,577 direct -1.1494 0.0 1 -1.1494 2

    WHITFIELD DIANNE C. - Officer CHIEF HUMAN RESOURCES OFFICER

    		2023-03-17 18:20:21 -0400 2023-03-16 S 313 $13.43 d 12,872 direct -1.1494 0.0 1 -1.1494 2

    GREENSTEIN LEONARD M. - Officer CHIEF FINANCIAL OFFICER

    		2023-03-17 18:04:40 -0400 2023-03-16 S 313 $13.43 d 38,438 direct -1.1494 0.0 1 -1.1494 2

    GREENSTEIN LEONARD M. - Officer CHIEF FINANCIAL OFFICER

    		2023-03-17 18:04:40 -0400 2023-03-16 S 5,000 $13.44 d 33,438 direct yes -1.1494 0.0 1 -1.1494 2

    AZAMIAN BOBAK R. - Director - Officer PRESIDENT/CEO AND BOARD CHAIR

    		2023-03-17 18:02:30 -0400 2023-03-16 S 791 $13.43 d 12,258 direct -1.1494 0.0 1 -1.1494 2

    WAHL BRYAN - Officer GENERAL COUNSEL

    		2023-03-17 18:21:16 -0400 2023-03-16 S 337 $13.43 d 18,176 direct -1.1494 0.0 1 -1.1494 2

    NEERVANNAN SESHADRI - Officer CHIEF OPERATING OFFICER

    		2023-03-17 18:15:59 -0400 2023-03-16 S 357 $13.43 d 56,577 direct -1.1494 0.0 1 -1.1494 2

    MOTTIWALA AZIZ - Officer CHIEF COMMERCIAL OFFICER

    		2023-03-17 18:17:06 -0400 2023-03-16 S 336 $13.43 d 54,604 direct -1.1494 0.0 1 -1.1494 2

    TREVEJO JOSE M. - Officer CHIEF MEDICAL OFFICER

    		2023-03-17 18:18:33 -0400 2023-03-16 S 499 $13.43 d 8,654 direct -1.1494 0.0 1 -1.1494 2

    WHITFIELD DIANNE C. - Officer CHIEF HUMAN RESOURCES OFFICER

    		2023-03-17 18:20:21 -0400 2023-03-15 M 4,462 a 13,185 direct -1.1494 0.0 1 -1.1494 2

    GREENSTEIN LEONARD M. - Officer CHIEF FINANCIAL OFFICER

    		2023-03-17 18:04:40 -0400 2023-03-15 M 4,462 a 38,751 direct -1.1494 0.0 1 -1.1494 2

    GREENSTEIN LEONARD M. - Officer CHIEF FINANCIAL OFFICER

    		2023-03-17 18:04:40 -0400 2023-03-15 M 4,462 d 13,388 direct

    AZAMIAN BOBAK R. - Director - Officer PRESIDENT/CEO AND BOARD CHAIR by the bobak azamian living trust established april 16, 2018

    		2023-03-17 18:02:30 -0400 2023-03-15 S 8,000 $13.79 d 1,080,536 indirect yes -1.1494 0.0 1 -1.1494 2

    AZAMIAN BOBAK R. - Director - Officer PRESIDENT/CEO AND BOARD CHAIR

    		2023-03-17 18:02:30 -0400 2023-03-15 M 11,299 a 13,049 direct -1.1494 0.0 1 -1.1494 2

    AZAMIAN BOBAK R. - Director - Officer PRESIDENT/CEO AND BOARD CHAIR

    		2023-03-17 18:02:30 -0400 2023-03-15 M 11,299 d 33,898 direct

    NEERVANNAN SESHADRI - Officer CHIEF OPERATING OFFICER

    		2023-03-17 18:15:59 -0400 2023-03-15 M 5,097 a 56,934 direct -1.1494 0.0 1 -1.1494 2

    NEERVANNAN SESHADRI - Officer CHIEF OPERATING OFFICER

    		2023-03-17 18:15:59 -0400 2023-03-15 M 5,097 d 15,291 direct

    TREVEJO JOSE M. - Officer CHIEF MEDICAL OFFICER

    		2023-03-17 18:18:33 -0400 2023-03-15 M 7,549 d 22,648 direct

    TREVEJO JOSE M. - Officer CHIEF MEDICAL OFFICER

    		2023-03-17 18:18:33 -0400 2023-03-15 M 7,549 a 9,153 direct -1.1494 0.0 1 -1.1494 2

    WAHL BRYAN - Officer GENERAL COUNSEL

    		2023-03-17 18:21:16 -0400 2023-03-15 M 4,790 d 14,370 direct

    WHITFIELD DIANNE C. - Officer CHIEF HUMAN RESOURCES OFFICER

    		2023-03-17 18:20:21 -0400 2023-03-15 M 4,462 d 13,388 direct

    HOLDBROOK MARK J. - Officer V.P., CLINICAL AFFAIRS

    		2023-03-17 18:22:23 -0400 2023-03-15 M 2,653 a 3,764 direct -1.1494 0.0 1 -1.1494 2

    HOLDBROOK MARK J. - Officer V.P., CLINICAL AFFAIRS

    		2023-03-17 18:22:23 -0400 2023-03-15 M 2,653 d 7,959 direct

    LINK WILLIAM J PHD - Director by flying l partners xi, llc

    		2023-03-17 18:39:00 -0400 2023-03-15 J 52,194 a 68,673 indirect -1.1494 0.0 1 -1.1494 2

    LINK WILLIAM J PHD - Director by flying l investments xi, llc

    		2023-03-17 18:39:00 -0400 2023-03-15 J 215,575 d 215,576 indirect yes -1.1494 0.0 1 -1.1494 2

    WAHL BRYAN - Officer GENERAL COUNSEL

    		2023-03-17 18:21:16 -0400 2023-03-15 M 4,790 a 18,513 direct -1.1494 0.0 1 -1.1494 2

    MOTTIWALA AZIZ - Officer CHIEF COMMERCIAL OFFICER

    		2023-03-17 18:17:06 -0400 2023-03-15 M 4,790 d 14,370 direct

    MOTTIWALA AZIZ - Officer CHIEF COMMERCIAL OFFICER

    		2023-03-17 18:17:06 -0400 2023-03-15 M 4,790 a 54,940 direct -1.1494 0.0 1 -1.1494 2

    AZAMIAN BOBAK R. - Director - Officer PRESIDENT/CEO AND BOARD CHAIR by the bobak azamian living trust established april 16, 2018

    		2023-03-10 17:13:32 -0500 2023-03-09 S 717 $15.01 d 1,088,536 indirect yes 0.8457 -8.0338 0.8457 2 -10.148 5

    AZAMIAN BOBAK R. - Director - Officer PRESIDENT/CEO AND BOARD CHAIR by the bobak azamian living trust established april 16, 2018

    		2023-03-10 17:13:32 -0500 2023-03-08 S 4,853 $15.02 d 1,089,253 indirect yes 0.8457 -8.0338 0.8457 2 -10.148 5

    AZAMIAN BOBAK R. - Director - Officer PRESIDENT/CEO AND BOARD CHAIR

    		2023-03-10 19:23:01 -0500 2023-03-08 A 67,900 a 67,900 direct

    AZAMIAN BOBAK R. - Director - Officer PRESIDENT/CEO AND BOARD CHAIR

    		2023-03-10 19:23:01 -0500 2023-03-08 A 100,242 a 100,242 direct

    WAHL BRYAN - Officer GENERAL COUNSEL

    		2023-03-10 19:29:51 -0500 2023-03-08 A 28,993 a 28,993 direct

    GREENSTEIN LEONARD M. - Officer CHIEF FINANCIAL OFFICER

    		2023-03-10 19:24:27 -0500 2023-03-08 A 27,160 a 27,160 direct

    GREENSTEIN LEONARD M. - Officer CHIEF FINANCIAL OFFICER

    		2023-03-10 19:24:27 -0500 2023-03-08 A 40,097 a 40,097 direct

    NEERVANNAN SESHADRI - Officer CHIEF OPERATING OFFICER

    		2023-03-10 19:26:33 -0500 2023-03-08 A 32,592 a 32,592 direct

    NEERVANNAN SESHADRI - Officer CHIEF OPERATING OFFICER

    		2023-03-10 19:26:33 -0500 2023-03-08 A 48,116 a 48,116 direct

    MOTTIWALA AZIZ - Officer CHIEF COMMERCIAL OFFICER

    		2023-03-10 19:25:25 -0500 2023-03-08 A 32,592 a 32,592 direct

    MOTTIWALA AZIZ - Officer CHIEF COMMERCIAL OFFICER

    		2023-03-10 19:25:25 -0500 2023-03-08 A 48,116 a 48,116 direct

    TREVEJO JOSE M. - Officer CHIEF MEDICAL OFFICER

    		2023-03-10 19:28:01 -0500 2023-03-08 A 30,792 a 30,792 direct

    TREVEJO JOSE M. - Officer CHIEF MEDICAL OFFICER

    		2023-03-10 19:28:01 -0500 2023-03-08 A 45,459 a 45,459 direct

    WAHL BRYAN - Officer GENERAL COUNSEL

    		2023-03-10 19:29:51 -0500 2023-03-08 A 42,802 a 42,802 direct

    WHITFIELD DIANNE C. - Officer CHIEF HUMAN RESOURCES OFFICER

    		2023-03-10 19:31:00 -0500 2023-03-08 A 28,993 a 28,993 direct

    WHITFIELD DIANNE C. - Officer CHIEF HUMAN RESOURCES OFFICER

    		2023-03-10 19:31:00 -0500 2023-03-08 A 42,802 a 42,802 direct

    GREENSTEIN LEONARD M. - Officer CHIEF FINANCIAL OFFICER

    		2023-02-17 16:58:53 -0500 2023-02-16 S 5,000 $15.12 d 34,289 direct yes 2.053 2.5828 2.5828 3 -0.7285 5

    AZAMIAN BOBAK R. - Director - Officer PRESIDENT/CEO AND BOARD CHAIR by the bobak azamian living trust established april 16, 2018

    		2023-02-17 16:54:55 -0500 2023-02-15 S 8,000 $15.28 d 1,094,106 indirect yes 2.053 2.5828 2.5828 3 -0.7285 5

    AZAMIAN BOBAK R. - Director - Officer PRESIDENT/CEO AND BOARD CHAIR by the bobak azamian living trust established april 16, 2018

    		2023-02-10 16:54:13 -0500 2023-02-08 S 9,000 $15.14 d 1,102,106 indirect yes 1.9193 -0.0662 2.5149 5 -0.0662 6

    * -

    Transaction Code Definitions
    Code Definition
    A Grant, award or other acquisition pursuant to Rule 16b-3(d)
    C Conversion of derivative security
    D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
    E Expiration of short derivative position
    F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
    G Bona fide gift
    H Expiration (or cancellation) of long derivative position with value received
    I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
    J Other acquisition or disposition
    L Small acquisition under Rule 16a-6
    M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
    O Exercise of out-of-the-money derivative security
    P Open market or private purchase of non-derivative or derivative security
    S Open market or private sale of non-derivative or derivative security
    U Disposition pursuant to a tender of shares in a change of control transaction
    W Acquisition or disposition by will or the laws of descent and distribution
    X Exercise of in-the-money or at-the-money derivative security
    Z Deposit into or withdrawal from voting trust

    IBR Securities Loan Availability

    Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

    Security Date/Time Rebate Rate Fee Rate Shares Available
    TARSUS PHARMACEUTICALS INC TARS 2023-03-24 22:15:03 UTC 4.1571 0.6629 1000000
    TARSUS PHARMACEUTICALS INC TARS 2023-03-24 21:45:03 UTC 4.1571 0.6629 1000000
    TARSUS PHARMACEUTICALS INC TARS 2023-03-24 21:15:03 UTC 4.1571 0.6629 1000000
    TARSUS PHARMACEUTICALS INC TARS 2023-03-24 20:45:03 UTC 4.1571 0.6629 1000000
    TARSUS PHARMACEUTICALS INC TARS 2023-03-24 20:15:04 UTC 4.1571 0.6629 1000000
    TARSUS PHARMACEUTICALS INC TARS 2023-03-24 19:45:03 UTC 4.1571 0.6629 1000000
    TARSUS PHARMACEUTICALS INC TARS 2023-03-24 19:15:04 UTC 4.1571 0.6629 1000000
    TARSUS PHARMACEUTICALS INC TARS 2023-03-24 18:45:04 UTC 4.1389 0.6811 1000000
    TARSUS PHARMACEUTICALS INC TARS 2023-03-24 18:15:03 UTC 4.1389 0.6811 1000000
    TARSUS PHARMACEUTICALS INC TARS 2023-03-24 17:45:03 UTC 4.1389 0.6811 1000000
    TARSUS PHARMACEUTICALS INC TARS 2023-03-24 17:15:03 UTC 4.1389 0.6811 1000000
    TARSUS PHARMACEUTICALS INC TARS 2023-03-24 16:45:03 UTC 4.1389 0.6811 1000000
    TARSUS PHARMACEUTICALS INC TARS 2023-03-24 16:15:03 UTC 4.1389 0.6811 950000
    TARSUS PHARMACEUTICALS INC TARS 2023-03-24 15:45:03 UTC 4.1389 0.6811 950000
    TARSUS PHARMACEUTICALS INC TARS 2023-03-24 15:15:03 UTC 4.1389 0.6811 1000000
    TARSUS PHARMACEUTICALS INC TARS 2023-03-24 14:45:03 UTC 4.1389 0.6811 1000000
    TARSUS PHARMACEUTICALS INC TARS 2023-03-24 14:15:03 UTC 4.1389 0.6811 950000
    TARSUS PHARMACEUTICALS INC TARS 2023-03-24 13:45:03 UTC 3.8695 0.7005 950000
    TARSUS PHARMACEUTICALS INC TARS 2023-03-24 13:15:04 UTC 3.8695 0.7005 950000
    TARSUS PHARMACEUTICALS INC TARS 2023-03-24 12:45:03 UTC 3.8695 0.7005 950000

    Current Active Short Positions

    Holder Issuer Net Short Position Position Date Origin

    No recent transactions

    *** To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***

    Elevate your investments